|
|
 |
|
Viewing report
|
|
|
|
The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Venture Planning Group, Feb 2010, Pages: 1,050
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems which will utilize amplification methods.In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new DNA probe and biochip technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next ten years.
This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the molecular diagnostics market during the next decade. The study explores business and technological trends in major markets; provides 5-and 10-year test volume and sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
Contains 1,050 pages and 96 tables
This report contains information not available from any other source, such as:
1) sales and market shares of major suppliers;
2) volume and sales forecasts by procedure, market segment, and country; and
3) specific new product development and business expansion opportunities for suppliers; and much more
Market Segments: Hospitals, Commercial Labs, Physician Offices, Blood Banks, Public Health Labs
According to the 7-country study from Venture Planning Group, the global molecular diagnostics market is growing at the rate of 18% a year, and is expected to reach $10 billion in 5 years. The most rapid growth is projected for genetic and cancer tests.
The report was prepared by VPG in order to assist diagnostics industry executives in evaluating emerging opportunities and developing effective business, R&D and marketing strategies for this dynamic and rapidly evolving market segment.
Report Content
This two-volume, 1050-page report contains 96 tables and presents the following information:
Worldwide Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing, by country and market segment.
- Ten-year test volume and sales projections, by country.
Market Segmentation Analysis
- Sales and market shares for Roche, Gen-Probe and other major suppliers of molecular diagnostc tests and kit components, by country.
- Ten-year test volume and sales forecasts for major DNA probes and NAT applications, including:
-- Infectious Diseases
-- Forensic Testing
-- Cancer
-- Paternity Testing/HLA Typing
-- Genetic Diseases
-- Others
- Ten-year test volume and sales projections for 30 molecular diagnostic assays.
- A comprehensive analysis of the DNA sequencing market, by country and laboratory segment, including:
-- Industrial
-- Academic
-- Government
-- Commercial
- A detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.
Product/Technology Review
- A comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and others.
- An extensive review of the molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
-- PCR
-- bDNA
-- SDA
-- NASBA
-- TMA
-- LCR
-- SSSR, and others
- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments
- Extensive (up to 7 pages each) strategic assessments of 45 major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new projects in R&D.
- Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
- 63 specific new product development opportunities with potentially significant market appeal during the next ten years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Customers who bought this item also bought
Future US Microbiology Testing Market Outlook
The 2011 Japanese Molecular Diagnostics Market
The 2011 US Molecular Diagnostics Market
Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Personalized Medicine - Scientific and Commercial Aspects
Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies
Future French Nucleic Acid Testing Market Outlook
Molecular Diagnostics: Market Segmentation and Opportunities - 4th Edition
French AIDS Diagnostic Market: Test Volumes, Sales Forecasts, and Supplier Shares
The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares
|
|
|
|
